Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

MEK1 monoclonal antibody (3D9)

ADI-905-635-100 100 µg 279.00 USD
Do you need bulk/larger quantities?

Product Specification

Alternative Name:MKK1, MAP kinase kinase 1
Immunogen:Native MEK and recombinant MEK1.
Source:Purified from mouse ascites.
Species reactivity:Human
Applications:ELISA, IHC, WB
Recommended Dilutions/Conditions:Immunohistochemistry (1µg/ml)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Application Notes:Detects a band of ~45kDa (or ~71kDa with GST tag) by Western blot.
Purity Detail:Protein G affinity purified.
Formulation:Liquid. In PBS containing 0.1% sodium azide. Concentration 1mg/ml.
Handling:Avoid freeze/thaw cycles.
Shipping:Shipped on Blue Ice
Long Term Storage:-20°C
Scientific Background:MEK is a dual specificity kinase capable of phosphorylating both tyrosine and threonine residues. The MEK family, which is also known as MAP kinase kinase, phosphorylates MAP kinases on the conserved T-X-Y motif; phosphorylation of MAPK by MEK results in an increase in MAPK activity. MEK is involved in a diverse array of cellular processes such as stress-activated response, apoptosis, cytokine-induced cell proliferation, and DNA recombination during meiosis.
Regulatory Status:RUO - Research Use Only
MEK1 monoclonal antibody (3D9) Immunohistochemistry
Immunohistochemistry analysis of brain tissue stained with anti-MEK clone 3D9.
MEK1 monoclonal antibody (3D9) Western blot
Western blot analysis of MEK1: Lane 1: MW marker, Lane 2: GST-tagged recombinant MEK1
Please mouse over
MEK1 monoclonal antibody (3D9) Immunohistochemistry MEK1 monoclonal antibody (3D9) Western blot

Product Toolbox


Certificate of Analysis


By target:
By biological activity:
MEK Monoclonal antibody
By catalog section:


Technical Service
Customer Service

Recommend this page

Keep in touch

©2020 Enzo Life Sciences, Inc.,